Form 8-K - Current report:
SEC Accession No. 0001193125-20-323913
Filing Date
2020-12-22
Accepted
2020-12-22 08:15:28
Documents
1
Period of Report
2020-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d72787d8k.htm 8-K 18727
  Complete submission text file 0001193125-20-323913.txt   19955
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 201406095
SIC: 2836 Biological Products, (No Diagnostic Substances)